Rob Ford to Undergo 40 Days of Chemotherapy (UPDATE)

By Staff Reporter - 18 Sep '14 06:56AM
Close

Doctors have revealed that Toronto Mayor Rob Ford will have to undergo 40 days of chemotherapy to treat the rare type of cancer that forced him to abandon his re-election bid.

His brother and campaign manager Doug Ford was formally registered Friday as a candidate in the Mayoral race in place of Rob.

Rob Ford is fighting Liposarcoma, which is a rare, aggressive and difficult-to-beat form of cancer that has a high rate of survival if caught early.

"The plan will be, initially, chemotherapy. We think it's fairly an aggressive tumor," said Dr. Zane Cohen, a colorectal surgeon at Mount Sinai hospital, Miami Herald reports.

According to the National Post, Dr. Malcom Moore - head of oncology at Mt. Sinai hospital, shared details of what Mayor Rob Ford might be facing in his fight against the malignant tumor, in  a press conference. He might also have to undergo a surgery, Toronto Sun reports.

Liposarcoma is a cancer of the soft tissue that includes muscles, tendons, connective tissues, fat, blood vessels, nerves and joint tissue. The cause of this type of cancer has not been ascertained as yet.

Amid building pressure to withdraw his candidature from the Mayoral race, Rob Ford continued to carry on his campaign in full swing, only to withdraw in the last minute citing health issues, News Everyday reports.

In May 2013, Gawker revealed that it had been offered videos of Ford smoking crack cocaine. The Mayor kept denying the charges and said that there was no way that such a video could exist. However, in a raid in November, when police recovered the video, Ford accepted the video must have been taken "during one of my drunken stupors," The Los Angeles Times reports.

Even though the controversy changed his image in the public eye, Ford is not ready to leave politics. He is set to run as a city council candidate in place of his nephew Michael Ford, who withdrew his candidacy Friday.

Fun Stuff

Join the Conversation

The Next Read

Real Time Analytics